Kalinyak Judith E, Kong Christina S, McDougall I Ross
Thyroid Clinic, Division of Nuclear Medicine, Stanford University School of Medicine, Stanford, California, USA.
Thyroid. 2006 Oct;16(10):1053-7. doi: 10.1089/thy.2006.16.1053.
A 53-year-old man was admitted to the hospital because of tracheal compressive symptoms from a rapidly expanding thyroid mass. The patient first noticed the nodule less than a week prior to admission. Thyroid tests were normal. A fine-needle aspiration (FNA) biopsy showed a monotonous population of intermediate-sized lymphoid cells with scant cytoplasm suspicious for lymphoma. Twelve hours later an emergent computed tomography (CT) scan confirmed left tracheal deviation with compression, however, there were no signs of tumor invasion. The patient received emergent CHOP (clophosphamide, adriamycin, vincristine, prednisone) and rituxan therapy. His mass completely resolved within 36 hours. Bone marrow biopsy provided the final diagnosis of stage IV Burkitt's lymphoma and his therapy was changed to hyper CVAD-R chemotherapy (cytoxan, vincristine, adriamycin, dexamethasone, rituxan). The patient's hospital course was complicated by tumor lysis syndrome that was managed by hydration and allopurinol. To our knowledge, this is only the second reported case of Burkitt's lymphoma presenting as a thyroid mass. His presentation highlights the urgency in diagnosis and provides an opportunity to review a rare type of primary thyroid lymphoma.
一名53岁男性因甲状腺肿块迅速增大导致气管受压症状入院。患者在入院前不到一周首次发现该结节。甲状腺检查正常。细针穿刺(FNA)活检显示一群中等大小的淋巴细胞,胞质稀少,怀疑为淋巴瘤。12小时后,急诊计算机断层扫描(CT)证实气管向左偏移并受压,但无肿瘤侵犯迹象。患者接受了紧急CHOP(环磷酰胺、阿霉素、长春新碱、泼尼松)和利妥昔单抗治疗。他的肿块在36小时内完全消退。骨髓活检最终诊断为IV期伯基特淋巴瘤,其治疗方案改为强化CVAD-R化疗(环磷酰胺、长春新碱、阿霉素、地塞米松、利妥昔单抗)。患者的住院过程因肿瘤溶解综合征而复杂化,通过补液和别嘌醇进行处理。据我们所知,这是第二例报告的以甲状腺肿块形式出现的伯基特淋巴瘤病例。他的病例突出了诊断的紧迫性,并提供了一个机会来回顾一种罕见的原发性甲状腺淋巴瘤。